Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK1605786 in active ulcerative colitis
NCT01658605Phase 2Withdrawn
- Sponsor
- GSK
- Start
- Feb 2013
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of vercirnon in ulcerative colitis (UC), sponsored by GSK. Planned start Feb 2013; status: withdrawn.
02
Drugs
vercirnon
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01658605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01658605.